Skip to main content
SpringerLink
Log in

Lifestyle and Pharmacology Approaches for the Treatment of Hypertension and Hyperlipidemia

  • Chapter
  • First Online:
Nutrition and Metabolism

Part of the book series: Nutrition and Health ((NH))

  • 2392 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thom T., Haase N., Rosamond W., et al Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85–e151.

    Article  PubMed  Google Scholar 

  2. Wang Y., Wang Q.J. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004;164:2126–2134.

    Article  PubMed  Google Scholar 

  3. Ford E.S., Mokdad A.H., Giles W.H., Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185–2189.

    Article  PubMed  Google Scholar 

  4. Stamler R. Implications of the INTERSALT study. Hypertension 1991;17:I16–I20.

    PubMed  CAS  Google Scholar 

  5. Sacks, F.M., Svetkey, L.P., Vollmer, W.M., et al Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3–10.

    Article  PubMed  CAS  Google Scholar 

  6. Appel L.J., Champagne C.M., Harsha D.W., et al Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003;289:2083–2093.

    Article  PubMed  Google Scholar 

  7. Estruch R., Martinez-Gonzalez M.A., Corella, D., et al Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006;145:1–11.

    PubMed  Google Scholar 

  8. Chobanian A.V., Bakris G.L., Black H.R., et al Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–1252.

    Article  PubMed  CAS  Google Scholar 

  9. Sorof J.M., Alexandrov A.V., Cardwell G., et al Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003;111:61–66.

    Article  PubMed  Google Scholar 

  10. Franklin S.S., Wachtell K., Papademetriou V., et al Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy. Hypertension 2005;46:492–499.

    Article  PubMed  CAS  Google Scholar 

  11. Julius S., Nesbitt S.D., Egan B.M., et al Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685–1697.

    Article  PubMed  CAS  Google Scholar 

  12. Lichtenstein A.H., Appel L.J., Brands M., et al Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82–96.

    Article  PubMed  Google Scholar 

  13. Klag M.J., Ford D.E., Mead L.A., et al Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313–318.

    Article  PubMed  CAS  Google Scholar 

  14. Castelli W.P. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984;76:4–12.

    Article  PubMed  CAS  Google Scholar 

  15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.

    Google Scholar 

  16. Castelli W.P. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988;4 Suppl A:5A–10A.

    PubMed  CAS  Google Scholar 

  17. Assmann G., Schulte H. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am J Cardiol 1992;70:10H–13H.

    Article  PubMed  CAS  Google Scholar 

  18. Mussoni L., Mannucci L., Sirtori M., et al Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb 1992;12:19–27.

    Article  PubMed  CAS  Google Scholar 

  19. Carvalho de Sousa J., Bruckert E., Giral P., et al Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 1989;19:125–130.

    PubMed  CAS  Google Scholar 

  20. Reaven G.M., Lerner R.L., Stern M.P., et al Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967;46:1756–1767.

    Article  PubMed  CAS  Google Scholar 

  21. Fontbonne A., Eschwege E., Cambien F., et al Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300–304.

    Article  PubMed  CAS  Google Scholar 

  22. Manninen V., Tenkanen L., Koskinen P., et al Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37–45.

    PubMed  CAS  Google Scholar 

  23. Sandhofer A., Kaser S., Ritsch A., et al Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring) 2006;14:812–818.

    Article  CAS  Google Scholar 

  24. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747–2757.

    Article  PubMed  Google Scholar 

  25. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711–1718.

    Article  PubMed  CAS  Google Scholar 

  26. Cannon C.P., Braunwald E., McCabe C.H., et al Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495–1504.

    Article  PubMed  CAS  Google Scholar 

  27. Sever P.S., Dahlof B., Poulter N.R., et al Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149–1158.

    Article  PubMed  CAS  Google Scholar 

  28. Colhoun H.M., Betteridge D.J., Durrington P.N., et al Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685–696.

    Article  PubMed  CAS  Google Scholar 

  29. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071–1080.

    Article  PubMed  CAS  Google Scholar 

  30. Nissen S.E., Nicholls S.J., Sipahi I., et al Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556–1565.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Beth Israel Deaconess, Medical Center, Harvard Medical School, Boston, MA, USA

    Peter Oettgen

Authors
  1. Peter Oettgen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2009 Humana Press, a part of Springer Science+Business Media, LLC

    About this chapter

    Cite this chapter

    Oettgen, P. (2009). Lifestyle and Pharmacology Approaches for the Treatment of Hypertension and Hyperlipidemia. In: Mantzoros, C. (eds) Nutrition and Metabolism. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-453-1_15

    Download citation

    • DOI: https://doi.org/10.1007/978-1-60327-453-1_15

    • Published:

    • Publisher Name: Humana Press

    • Print ISBN: 978-1-60327-452-4

    • Online ISBN: 978-1-60327-453-1

    • eBook Packages: MedicineMedicine (R0)

    Publish with us

    Policies and ethics

    Search

    Navigation